Studies have shown that high expression levels of IL-6 and TNF-α in breast cancer can lead to a decrease in survival and a significant increase in mortality, which is beneficial to the progression and dissemination of breast cancer [44]. This evidence concerns the gene IL6 and breast carcinoma.